Scientists search for clues in brain cancer blood tests
NCT ID NCT06222138
Summary
This study aims to understand why some glioblastoma brain tumors respond better than others to TTFields treatment. Researchers will collect blood samples and existing tumor tissue from 80 newly diagnosed patients to look for biological markers that predict treatment success. The study does not test any new treatments but seeks to improve future care by understanding treatment resistance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUCT-O
RECRUITINGToulouse, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.